Health - Minutes of Evidence [Back to Report]

---

Here you can browse the Minutes of Evidence which were ordered by the House of Commons to be printed 20 June 2002.

WEDNESDAY 23 JANUARY 2002

---

Members present:

Mr David Hinchliffe, in the Chair

Mr David Amess	Sandra Gidley
Andy Burnham	Siobhain McDonagh
Mr Simon Burns	Dr Doug Naysmith
Jim Dowd	Dr Richard Taylor

---

CONTENTS

Memorandum by Helen Marlow, Pharmaceutical Adviser, Croydon Health Authority (NC 31)

Memorandum by Dr Tim Crayford, Deputy Director of Public Health and Chairman Prescribing Committee, Croydon Health Authority (NC 32)

Memorandum by Lambeth, Southwark and Lewisham Health Authority (NC 47)

Memorandum by Newcastle and North Tyneside Health Authority (NC 112)

Examination of Witnesses

DR TIM CRAYFORD, Deputy Director of Public Health and Chairman, Prescribing Committee and HELEN MARLOW, Pharmaceutical Adviser, Croydon Health Authority, DR DEIRDRE CUNNINGHAM, Director of Public Health and Health Systems, Lambeth Southwark and Lewisham Health Authority and DR DAVID WALKER, Director of Public Health, Newcastle and North Tyneside Health Authority, examined.

Question Number

135 - 139

140 - 159

160 - 179

180 - 199

200 - 210

Memorandum by the Association of the British Pharmaceutical Industry (NC 118)

Annex 1

Annex 2

Annex 3

Memorandum by GlaxoSmithKline (NC 120)

Memorandum by Campaign for Effective and Rational Treatment (CERT) (NC 23)

Examination of Witnesses

MR EDDIE GRAY, General Manager and Senior Vice-President, GlaxoSmithKline, MR HUGH MCKINNEY, Director and MR DAVID CAMPBELL-MORRISON, Director, Campaign for Effective and Rational Treatment (CERT) and DR TREVOR JONES, Director General, MR BILL FULLAGAR, Chairman of Novartis UK and President, DR JOHN PATTERSON, Executive Vice-President, Product Strategy and Licensing, AstraZeneca and President-elect, Association of the British Pharmaceutical Industry, examined.

Question Number

211 - 219

220 - 239

240 - 259

260 - 279

280 - 296

---

---

Prepared 8 July 2002